다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

홈
인베스팅
주식
미국
NASDAQ
Capricor Therapeutics Inc (CAPR)
Capricor Therapeutics Inc (CAPR) 뉴스

CAPR

Capricor Therapeutics (CAPR)

Capricor Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CAPR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/06/17	06:00	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/06/11	22:25	GlobeNewswire Inc.	Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/05/15	05:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/05/14	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/05/14	05:05	GlobeNewswire Inc.	Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/05/13	22:00	GlobeNewswire Inc.	Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/05/06	22:15	GlobeNewswire Inc.	Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/05/05	21:00	GlobeNewswire Inc.	Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/04/10	06:15	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/04/09	06:15	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/04/09	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/04/01	22:00	GlobeNewswire Inc.	Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/27	05:15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/20	05:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/20	05:05	GlobeNewswire Inc.	Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/17	22:25	GlobeNewswire Inc.	Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/11	22:00	GlobeNewswire Inc.	Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/10	22:13	PR Newswire (US)	FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/07	23:25	GlobeNewswire Inc.	Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/06	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/05	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/05	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/05	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/04	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/04	21:00	GlobeNewswire Inc.	Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/03/01	09:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/02/10	23:00	GlobeNewswire Inc.	Capricor Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/02/06	07:20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/01/07	09:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CAPR	Capricor Therapeutics Inc
2025/01/07	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CAPR	Capricor Therapeutics Inc

검색 관련기사 보기:NASDAQ:CAPR

1 2 3 4 5 6 7 8 9 10 다음 >>

JP Morgan Chase

Bank of America

Gold vs US Dollar

Health Care Select Sector

BNP Paribas (QX)

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관